Results 91 to 100 of about 6,140 (133)

Prediction of human pharmacokinetics of Fc-engineered therapeutic monoclonal antibodies using human FcRn transgenic mice. [PDF]

MAbs
Haraya K, Ichikawa T, Murao N, Katada H, Kuramochi T.   +4 more
europepmc   +1 more source

Targeted Treatment of Sarcomas by Single Protein Encapsulated Doxorubicin with Undetectable Cardiotoxicity and Superior Efficacy. [PDF]

Cancers (Basel)
Yu C, Huang F, Wang L, Liu M, Chow WA, Ling X, Li F, Cook-Wiens G, Li L, Cui X.   +9 more
europepmc   +1 more source

Reducing IgG accumulation via neonatal Fc receptor (FcRn) blockade relieves neuropathic pain. [PDF]

Brain Behav Immun
Fiore NT, Willcox KF, Dayani D, Zuberi YA, Heijnen CJ, Grace PM.   +5 more
europepmc   +1 more source

Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life. [PDF]

PNAS Nexus
Mester S, Chan C, Lustig M, Foss S, Jansen JHM, Leangen Herigstad M, Evers M, Nilsen J, Reiding KR, A Damen JM, Burger R, Grevys A, Dalhus B, Valerius T, Sandlie I, Leusen JHW, Andersen JT.   +16 more
europepmc   +1 more source

Downregulation of FcRn promotes ferroptosis in herpes simplex virus-1-induced lung injury. [PDF]

Cell Mol Life Sci
Qian S, Zhang D, Li R, Sha X, Lu S, Pan L, Hui X, Zhao T, Song X, Yu L.   +9 more
europepmc   +1 more source

HIV-related Differences in Placental Immunology: Data From the PRACHITi Cohort in Pune, India. [PDF]

Open Forum Infect Dis
Mathad JS, Alexander M, Bhosale R, Naik S, Cranmer LM, Kulkarni V, Busch S, Chalem A, Gitlin E, Lei J, Liu A, Liu J, Liu Y, Shivakoti R, Gupta A, Burd I.   +15 more
europepmc   +1 more source

C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis. [PDF]

J Neurol Neurosurg Psychiatry
Huntemann N, Gerischer L, Herdick M, Nelke C, Stascheit F, Hoffmann S, Öztürk M, Schroeter CB, Lehnerer S, Stein M, Schubert C, Schneider-Gold C, Pfeuffer S, Krämer HH, Konen FF, Skripuletz T, Pawlitzki M, Glaubitz S, Zschüntzsch J, Scherwietes V, Totzeck A, Hagenacker T, Meuth SG, Meisel A, Ruck T.   +24 more
europepmc   +1 more source

Physiologically Based Pharmacokinetic Models for Infliximab, Ipilimumab, and Nivolumab Developed with GastroPlus to Predict Hepatic Concentrations. [PDF]

Pharmaceutics
Vallejo C, Meaney C, Clemens L, Yang K, Lukacova V, Zhou H.   +5 more
europepmc   +1 more source

Case Report: A myasthenia gravis patient complicated with renal failure was effectively treated with efgartigimod. [PDF]

Front Immunol
Ke J, Zhao Q, Wang N, Zhang B, Hu JQ.
europepmc   +1 more source

Targeting the neonatal Fc receptor (FcRn) is not beneficial in an animal model of chronic neuritis. [PDF]

Immunol Res
Mausberg AK, Szepanowski F, Eggert B, Liebig KC, Kleinschnitz C, Kieseier BC, Stettner M.   +6 more
europepmc   +1 more source